R&D to develop Ganaxolone to treat status epilepticus
Award Notice Posted
- Solicitation number
- 75A50120C00159
- Agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Awarded
- to Immedica Pharma US Inc.
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75A50120C00159 Federal contract award
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- Not on record
- Place of performance
- Radnor PA 19087 USA
Notice details come from SAM.gov. Updated .
About this opportunity
This Award Notice from the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response announces a negotiated cost reimbursement contract awarded to Marinus Pharmaceuticals, Inc. on September 8, 2020. The contract, valued at $5,148,017.40, is for research and development efforts to develop Ganaxolone, a drug intended to treat status epilepticus.
Notice text
NEGOTIATED COST REIMBURSEMENT COST SHARE CONTRACT PER BAA-18-SOL-00003
Awarded contract 75A50120C00159 to MARINUS PHARMACEUTICALS, INC. for 51480174.00 on 2020-09-08.
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity